Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Direct head-to-head data against tirzepatide showed CagriSema underperforming the highest tirzepatide dose at 84 weeks meaning monotherapy claims of comparable efficacy are not supported by current Phase 3 evidence
Good for energy
The peptide market is booming, especially in recovery and anti-aging
People report improvements in skin texture, elasticity, faster healing of marks and blemishes, and some hair benefit - but over weeks, not days
Do not exceed recommended daily dose
US$ 24.97
US$ 21.24
US$ 22.12
US$ 25.82
